Biotech News

Home Biotech News

No posts to display

- Advertisement -

APPLE

Minerva Neurosciences Stock Plunges After Schizophrenia Trial Results

Shares of Massachusetts-based biotechnology company Minerva Neurosciences (NASDAQ:NERV) cratered late last week following the company's announcement of disappointing results from its phase 3 trial...

RECENT POSTS